VANCOUVER, BC / ACCESS Newswire / January 26, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed. A new artificial intelligence ...

The next doctor insisted a breast exam was necessary after I described the weakness that turned my legs into Jell-O.

Looking for something fun to do in Pueblo in the days ahead? Here are some of the Steel City's top options through Feb. 13.

Sanofi (NASDAQ:SNY) executives told investors the company delivered “strong performance” in 2025 as it continued its shift ...

ProMIS Neurosciences Inc. ("ProMIS" or the "Company"), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded ...

An estimated 60% of patients with Alzheimer's disease develop epilepsy or subclinical epileptiform activity over the course of the disease. New-onset seizures in cognitively healthy adults also ...